News Category
Nano-X Imaging Ltd. is assembling an integrated platform to extend 3D medical imaging to underserved settings, aiming to close a stark global access g...
HeartBeam is pioneering portable, cable-free ECG systems that synthesize 12-lead ECGs, aiming to expand cardiac monitoring beyond clinical settings an...
HeartBeam Inc. is expanding cardiac care by enabling 12-lead ECG monitoring outside clinical settings, leveraging its FDA-cleared portable system to p...
HeartBeam Inc. has completed patient enrollment earlier than expected in its ALIGN-ACS pilot study, evaluating its 3D ECG system for heart attack dete...
Hong Kong Science and Technology Parks Corporation (HKSTP) led a record 41-strong delegation to BIO 2026 in San Diego, highlighting Hong Kong's role a...
Quantum BioPharma's co-founder discusses the company's promising MS drug candidate Lucid-MS and commercial alcohol metabolism product unbuzzd™, highli...
Regentis Biomaterials is progressing its cell-free hydrogel implant GelrinC through pivotal trials, targeting a $3 billion U.S. market for knee cartil...
Quantum BioPharma's co-founder discusses the potential of Lucid-MS for multiple sclerosis and the commercial success of unbuzzd, with an upcoming Phas...
Regentis Biomaterials advances GelrinC, a cell-free hydrogel implant for knee cartilage repair, toward European commercialization and U.S. Phase III t...
Regentis Biomaterials is nearing U.S. FDA approval for its off-the-shelf GelrinC hydrogel implant, targeting a market of 472,500 annual knee cartilage...
Regentis Biomaterials' cell-free hydrogel implant GelrinC aims to simplify knee cartilage repair, targeting a $3 billion U.S. market with promising cl...
VERAXA Biotech AG secured $27.5 million in senior secured convertible note financing from High Trail Capital and a $50 million equity line from Lincol...
MindBio Therapeutics has filed patent applications for 15 novel discoveries in AI-driven voice intoxication detection, targeting industries like minin...
